Inhibition of Thrombus Formation by Endothelin-1 in Canine Models of Arterial Thrombosis

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Thrombosis and Haemostasis

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0038-1649986PMID 8772241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.

  1994cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

  1994cited by this paper
• Prevention of Rethrombosis After Coronary Thrombolysis in a Chronic Canine Model. I. Adjunctive Therapy with Monoclonal Antibody 7E3 F(ab')2 Fragment

  1994cited by this paper
• Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody.

  1994cited by this paper
• Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension.

  1993cited by this paper
• The snake venom peptide sarafotoxin S6b inhibits repetitive platelet thrombus formation in the stenosed canine coronary artery.

  1993cited by this paper
• In vitro inhibition by endothelins of thrombin‐induced aggregation and Ca2+ mobilization in human platelets

  1992cited by this paper
• The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo.

  1992cited by this paper
• Chronic hypoxia changes the ratio of endothelin to ATP release from rat aortic endothelial cells exposed to high flow

  1992cited by this paper
• Comparative study of the adverse effects of various radiographic contrast media, including ioversol, a new low-osmolarity medium. II. The complement system and endothelial cells.

  1991cited by this paper
• Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin.

  1991cited by this paper
• Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

  1991cited by this paper
• Endothelin-1 and human platelet activity.

  1991cited by this paper
• Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells.

  1991influential reference
• Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.

  1990cited by this paper
• Increased plasma endothelin level in patients with essential hypertension.

  1990cited by this paper
• Endothelin‐1 inhibits platelet aggregation in vivo: a study with 111indium‐labelled platelets

  1990cited by this paper
• In vivo models of arterial thrombosis and thrombolysis

  1990cited by this paper
• Circulating immunoreactive endothelin in ischemic heart disease.

  1990cited by this paper
• Plasma endothelin levels in hypertension and chronic renal failure.

  1990cited by this paper
• Endothelin and platelet function.

  1990cited by this paper
• Failure of endothelin to influence in vitro platelet responses.

  1989cited by this paper
• Concomitant secretion of big endothelin and its C-terminal fragment from human and bovine endothelial cells.

  1989cited by this paper
• Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells.

  1989cited by this paper
• Endothelin‐1 Releases Prostacyclin and Inhibits ex vivo Platelet Aggregation in the Anesthetized Rabbit

  1989cited by this paper
• Prostacyclin mediates antiaggregatory and hypotensive actions of endothelin in anaesthetized beagle dogs

  1989cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Endothelin inhibits ex vivo platelet aggregation in the rabbit.

  1988cited by this paper
• Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

  1988cited by this paper
• Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model.

  1986cited by this paper
• Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.

  1980cited by this paper
• Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).

  1980cited by this paper

• Effect of prednisone administration on coagulation variables in healthy Beagle dogs.

  2011cites this paper
• Imaging thromboembolism with fibrin-avid 99mTc-peptide: evaluation in swine.

  2006cites this paper
• Biological properties of a specific Gαq/11 inhibitor, YM‐254890, on platelet functions and thrombus formation under high‐shear stress

  2006cites this paper
• Imaging VascularThrombosis with 99mTc@Labeled Fibrin a-Chain Peptide

  2000cites this paper
• Imaging vascular thrombosis with 99mTc-labeled fibrin alpha-chain peptide.

  2000cites this paper
• Imaging thromboembolism with Tc-99m-labeled thrombospondin receptor analogs TP-1201 and TP-1300.

  1999cites this paper
• Endothelial dysfunction following thrombolysis in vitro.

  1998cites this paper
• Endothelin-1 and unstable angina: effect of either endothelin ET(A) or ET(B) receptor antagonism in a locally injured canine coronary artery.

  1998cites this paper
• Effect of endothelin on the regulation of the fibrinolytic system of cultured human vascular smooth muscle cells

  1997cites this paper
• Haemostatic changes in the pulmonary blood during cardiopulmonary bypass.

  1996cites this paper